Prognosis of patients with prostate carcinoma presenting as nonregional lymph node metastases

Urologia Internationalis

Volumn 61, Issue 1, 1998, Pages 17-21

  Furuya, Yuzo ^a   Akakura, Koichiro ^a   Akimoto, Susumu ^a   Ito, Haruo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Endocrine therapy; Nonregional lymph node; Prostate cancer

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0031770232     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030277     Document Type: Article

References (15)

1. Catalona WJ, Scott WW: Carcinoma of the prostate. J Urol 1978;119:1-8.
2. Isaacs JT, Furuya Y, Berges R: The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Semin Cancer Biol 1994;5:391-400.
3. Shimazaki J, Isaka S, Akimoto S, Sumiya H, Masai M, Ichikawa T, Akakura K, Furuya Y: Mechanism of relapse in prostate cancer. Akt Urol 1990;21:22-24.
4. Catalona WJ, Scott WW: Carcinoma of the prostate; in Campbell's Urology, ed 5, Philadelphia, Saunders, 1986, pp 1463-1534.
5. Corriere JN, Cornog JL, Murphy JJ: Prognosis in patients with carcinoma of the prostate. Cancer 1970;25.911-918.
6. Harmer MH: TNM Classification of Malignant Tumours, ed 3. Geneva, International Union against Cancer, 1978.
7. Gleason DF, Mellinger GT, the Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
8. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, Moinuddin M: Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988;61:195-202.
9. Kuriyama M, Akimoto S, Akaza H, Arai Y, Usami M, Imai K, Tanaka Y, Yamazaki H, Kawada Y, Koiso K, Yoshida O, Kotake T, Yamanaka H, Machida T, Aso Y, Shimazaki J: Comparison of various assay systems for prostate-specific antigen standardization. Jpn J Clin Oncol 1992;22:393-399.
10. 2 prostatic cancer: Cancer 1988;61:1425-1429.
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
12. Cox DR: Regression models and life tables. J R Stat Soc 1972;34:187-220.
13. McCullough DL, Prout GR, Daly JJ: Carcinoma of the prostate and lymphatic metastasis. J Urol 1974;111:65-71.
14. Reynard IM, Peters TJ, Gillatt D: Prostate-specific antigen and prognosis in patients with metastatic prostate cancer: A multivariable analysis of prostate cancer mortality. Br J Urol 1995;75:507-515.
15. Arai Y, Yoshida O: A heterogeneous pattern of progression in endocrine-treated patients with prostate cancer. Eur Urol 1996;29:331-336.